CoChat

NEUROBIOLOGICAL PREDICTORS OF RESPONSE TO DORSOLATERAL PREFRONTAL CORTEX REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN DEPRESSION: A SYSTEMATIC REVIEW: Review: Biological Predictors of Response to rTMS

Open access
Silverstein, William K., Noda, Yoshihiro, Barr, Mera S., Vila-Rodriguez, Fidel, Rajji, Tarek K., Fitzgerald, Paul B., Downar, Jonathan, Mulsant, Benoit H., Vigod, Simone, Daskalakis, Zafiris J., Blumberger, Daniel M. · 2015 · Depression and Anxiety
Cited by 76

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

BACKGROUND: A significant proportion of patients with depression fail to respond to psychotherapy and standard pharmacotherapy, leading to treatment-resistant depression (TRD). Due to the significant prevalence of TRD, alternative therapies for depression have emerged as viable treatments in the armamentarium for this disorder. Repetitive transcranial magnetic stimulation (rTMS) is now being offered in clinical practice in broader numbers. Many studies have investigated various different neurobiological predictors of response of rTMS. However, a synthesis of this literature and an understanding of what biological targets predict response is lacking. This review aims to systematically synthesize the literature on the neurobiological predictors of rTMS in patients with depression. METHODS: Medline (1996-2014), Embase (1980-2014), and PsycINFO (1806-2014) were searched under set terms. Two authors reviewed each article and came to consensus on the inclusion and exclusion criteria. All eligible studies were reviewed, duplicates were removed, and data were extracted individually. RESULTS: The search identified 1,673 articles, 41 of which met both inclusion and exclusion criteria. Various biological factors at baseline appear to predict response to rTMS, including levels of certain molecular factors, blood flow in brain regions implicated in depression, electrophysiological findings, and specific genetic polymorphisms. CONCLUSIONS: Significant methodological variability in rTMS treatment protocols limits the ability to generalize conclusions. However, response to treatment may be predicted by baseline frontal lobe blood flow, and presence of polymorphisms of the 5-hydroxytryptamine (5-HT) -1a gene, the LL genotype of the serotonin transporter linked polymorphic region (5-HTTLPR) gene, and Val/Val homozygotes of the brain-derived neurotrophic factor (BDNF) gene.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/da.22424

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 58

  1. Murray, 2012, Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet, 380, 2197, 10.1016/S0140-6736(12)61689-4 · DOI · Paper page
  2. Lepine, 2011, The increasing burden of depression, Neuropsychiatr Dis Treat, 7, 3
  3. Nemeroff, 2007, Prevalence and management of treatment-resistant depression, J Clin Psychiatry, 68, 17
  4. O'Reardon, 2007, Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial, Biol Psychiatry, 62, 1208, 10.1016/j.biopsych.2007.01.018 · DOI · Paper page
  5. George, 2013, The expanding evidence base for rTMS treatment of depression, Curr Opin Psychiatry, 26, 13, 10.1097/YCO.0b013e32835ab46d · DOI · Paper page
  6. Schutter, 2009, Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis, Psychol Med, 39, 65, 10.1017/S0033291708003462 · DOI · Paper page
  7. Birkett, 1994, Internal pilot studies for estimating sample size, Stat Med, 13, 2455, 10.1002/sim.4780132309 · DOI · Paper page
  8. Schoenfeld, 1980, Statistical considerations for pilot studies, Int J Radiat Oncol Biol Phys, 6, 371, 10.1016/0360-3016(80)90153-4 · DOI · Paper page
  9. Eschweiler, 2000, Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression, Psychiat Res Neuroim, 99, 161, 10.1016/S0925-4927(00)00062-7 · DOI · Paper page
  10. Hernandez-Ribas, 2013, Identifying brain imaging correlates of clinical response to repetitive transcranial magnetic stimulation (rTMS) in major depression, Brain Stimul, 6, 54, 10.1016/j.brs.2012.01.001 · DOI · Paper page
  11. Kimbrell, 1999, Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism, Biol Psychiatry, 46, 1603, 10.1016/S0006-3223(99)00195-X · DOI · Paper page
  12. Zanardi, 2007, Role of serotonergic gene polymorphisms on response to transcranial magnetic stimulation in depression, Eur Neuropsychopharmacol, 17, 643, 10.1016/j.euroneuro.2007.03.008 · DOI
  13. Baeken, 2010, Brain Stimul, 3, 54, 10.1016/j.brs.2009.03.008 · DOI
  14. Fitzgerald, 2004, Motor cortical excitability and clinical response to rTMS in depression, J Affect Disord, 82, 71, 10.1016/j.jad.2003.09.014 · DOI
  15. Widge, 2013, Baseline and treatment-emergent EEG biomarkers of antidepressant medication response do not predict response to repetitive transcranial magnetic stimulation, Brain Stimul, 6, 929, 10.1016/j.brs.2013.05.001 · DOI
  16. Krstić, 2014, Low-frequency repetitive transcranial magnetic stimulation in the right prefrontal cortex combined with partial sleep deprivation in treatment-resistant depression: a randomized sham-controlled trial, J ECT, 10.1097/YCT.0000000000000099 · DOI · Paper page
  17. Narushima, 2010, Subgenual cingulate theta activity predicts treatment response of repetitive transcranial magnetic stimulation in participants with vascular depression, J Neuropsychiatry Clin Neurosci, 22, 75, 10.1176/jnp.2010.22.1.75 · DOI · Paper page
  18. Speer, 2009, Opposite effects of high and low frequency rTMS on mood in depressed patients: relationship to baseline cerebral activity on PET, J Affect Disord, 115, 386, 10.1016/j.jad.2008.10.006 · DOI · Paper page
  19. Furtado, 2012, Cognitive and volumetric predictors of response to repetitive transcranial magnetic stimulation (rTMS)-a prospective follow-up study, Psychiatry Res, 202, 12, 10.1016/j.pscychresns.2012.02.004 · DOI
  20. Pretalli, 2012, Resting motor threshold changes and clinical response to prefrontal repetitive transcranial magnetic stimulation in depressed patients, Psychiatry Clin Neurosci, 66, 344, 10.1111/j.1440-1819.2012.02341.x · DOI
  21. Bocchio-Chiavetto, 2008, 5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression, Neurosci Lett, 437, 130, 10.1016/j.neulet.2008.04.005 · DOI
  22. Kito, 2012, Cerebral blood flow in the ventromedial prefrontal cortex correlates with treatment response to low-frequency right prefrontal repetitive transcranial magnetic stimulation in the treatment of depression, Psychiatry Clin Neurosci, 66, 138, 10.1111/j.1440-1819.2011.02312.x · DOI · Paper page
  23. O'Reardon, 2007, Patients with a major depressive episode responding to treatment with repetitive transcranial magnetic stimulation (rTMS) are resistant to the effects of rapid tryptophan depletion, Depress Anxiety, 24, 537, 10.1002/da.20261 · DOI · Paper page
  24. Richieri, 2011, Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression, Eur J Nucl Med Mol Imaging, 38, 1715, 10.1007/s00259-011-1850-9 · DOI
  25. Arns, 2012, Neurophysiological predictors of non-response to rTMS in depression, Brain Stimul, 5, 569, 10.1016/j.brs.2011.12.003 · DOI · Paper page
  26. Huang, 2008, Effect of age, gender, menopausal status, and ovarian hormonal level on rTMS in treatment-resistant depression, Psychoneuroendocrinology, 33, 821, 10.1016/j.psyneuen.2008.03.006 · DOI
  27. Kito, 2012, Cerebral blood flow ratio of the dorsolateral prefrontal cortex to the ventromedial prefrontal cortex as a potential predictor of treatment response to transcranial magnetic stimulation in depression, Brain Stimul, 5, 547, 10.1016/j.brs.2011.09.004 · DOI
  28. Langguth, 2007, Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS), Neuroendocrinol Lett, 28, 633
  29. Malaguti, 2011, Role of COMT, 5-HT1A, and SERT genetic polymorphisms on antidepressant response to transcranial magnetic stimulation, Depress Anxiety, 28, 568, 10.1002/da.20815 · DOI · Paper page
  30. Micoulaud-Franchi, 2012, Parieto-temporal alpha EEG band power at baseline as a predictor of antidepressant treatment response with repetitive transcranial magnetic stimulation: a preliminary study, J Affect Disord, 137, 156, 10.1016/j.jad.2011.12.030 · DOI · Paper page
  31. Pallanti, 2012, Low-frequency rTMS over right dorsolateral prefrontal cortex in the treatment of resistant depression: cognitive improvement is independent from clinical response, resting motor threshold is related to clinical response, Neuropsychobiology, 65, 227, 10.1159/000336999 · DOI · Paper page
  32. Weiduschat, 2013, Prefrontal cortical blood flow predicts response of depression to rTMS, J Affect Disord, 150, 699, 10.1016/j.jad.2013.04.049 · DOI
  33. Li, 2013, Impaired prefronto-thalamic functional connectivity as a key feature of treatment-resistant depression: a combined MEG, PET and rTMS study, PLoS One, 8, e70089, 10.1371/journal.pone.0070089 · DOI · Paper page
  34. Baeken, 2009, HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging, CNS Spectr, 14, 439, 10.1017/S1092852900020411 · DOI · Paper page
  35. Nadeau, 2002, Cerebral blood flow changes in depressed patients after treatment with repetitive transcranial magnetic stimulation: evidence of individual variability, Neuropsychiatry Neuropsychol Behav Neurol, 15, 159
  36. Zwanzger, 2003, The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression, Psychoneuroendocrinology, 28, 376, 10.1016/S0306-4530(02)00029-X · DOI
  37. Baeken, 2011, The impact of HF-rTMS treatment on serotonin2A receptors in unipolar melancholic depression, Brain Stimul, 4, 104, 10.1016/j.brs.2010.09.002 · DOI · Paper page
  38. Luborzewski, 2007, Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression, J Psychiatr Res, 41, 606, 10.1016/j.jpsychires.2006.02.003 · DOI
  39. Price, 2008, Appraisal of sessional EEG features as a correlate of clinical changes in an rTMS treatment of depression, Clin EEG Neurosci, 39, 131, 10.1177/155005940803900307 · DOI
  40. Li, 2010, Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism, J Affect Disord, 127, 219, 10.1016/j.jad.2010.05.028 · DOI
  41. Mottaghy, 2002, Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients, Psychiatry Res, 115, 1, 10.1016/S0925-4927(02)00032-X · DOI · Paper page
  42. Teneback, 1999, Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS, J Neuropsychiatry Clin Neurosci, 11, 426, 10.1176/jnp.11.4.426 · DOI · Paper page
  43. Kito, 2008, Regional cerebral blood flow changes after low-frequency transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in treatment-resistant depression, Neuropsychobiology, 58, 29, 10.1159/000154477 · DOI · Paper page
  44. Kito, 2008, Changes in regional cerebral blood flow after repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in treatment-resistant depression, J Neuropsychiatry Clin Neurosci, 20, 74, 10.1176/jnp.2008.20.1.74 · DOI · Paper page
  45. Takahashi, 2013, Cerebral blood flow in the subgenual anterior cingulate cortex and modulation of the mood-regulatory networks in a successful rTMS treatment for major depressive disorder, Neurocase, 19, 262, 10.1080/13554794.2012.667121 · DOI
  46. Furtado, 2013, An investigation of medial temporal lobe changes and cognition following antidepressant response: a prospective rTMS study, Brain Stimul, 6, 346, 10.1016/j.brs.2012.06.006 · DOI · Paper page
  47. Conca, 2002, Combining high and low frequencies in rTMS antidepressive treatment: preliminary results, Hum Psychopharmacol, 17, 353, 10.1002/hup.422 · DOI · Paper page
  48. Oberlander, 2009, Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence, Clin Pharmacol Ther, 86, 672, 10.1038/clpt.2009.201 · DOI · Paper page
  49. Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, e1000097, 10.1371/journal.pmed.1000097 · DOI · Paper page
  50. Brunoni, 2008, Can the ‘yin and yang’ BDNF hypothesis be used to predict the effects of rTMS treatment in neuropsychiatry?, Med Hypotheses, 71, 279, 10.1016/j.mehy.2008.02.011 · DOI
  51. Downar, 2014, Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression, Biol Psychiatry, 76, 176, 10.1016/j.biopsych.2013.10.026 · DOI · Paper page
  52. Arns, 2014, Non-linear EEG analyses predict non-response to rTMS treatment in major depressive disorder, Clin Neurophysiol, 125, 1392, 10.1016/j.clinph.2013.11.022 · DOI
  53. Erguzel, 2015, Neural network based response prediction of rTMS in major depressive disorder using QEEG cordance, Psychiatry Investig, 12, 61, 10.4306/pi.2015.12.1.61 · DOI
  54. Noda, 2015, Neurobiological mechanisms of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex in depression: a systematic review, Psychol Med, 10.1017/S0033291715001609 · DOI · Paper page
  55. Baeken, 2014, Accelerated HF-rTMS in treatment-resistant unipolar depression: insights from subgenual anterior cingulate functional connectivity, World J Biol Psychiatry, 15, 286, 10.3109/15622975.2013.872295 · DOI · Paper page
  56. Singh, 2006, Altered balance of glutamatergic/GABAergic synaptic input and associated changes in dendrite morphology after BDNF expression in BDNF-deficient hippocampal neurons, J Neurosci, 26, 7189, 10.1523/JNEUROSCI.5474-05.2006 · DOI
  57. Tabata, 2010, GABAB receptor-mediated modulation of metabotropic glutamate signaling and synaptic plasticity in central neurons, Adv Pharmacol, 58, 149, 10.1016/S1054-3589(10)58007-4 · DOI
  58. Chen, 2013, Left versus right repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomised controlled trials, Psychiatry Res, 210, 1260, 10.1016/j.psychres.2013.09.007 · DOI · Paper page

Cited by

Metadata

Authors
Silverstein, W. K., Noda, Y., Barr, M. S., Vila-Rodriguez, F., Rajji, T. K., Fitzgerald, P. B., Downar, J., Mulsant, B. H., Vigod, S., Daskalakis, Z. J., & Blumberger, D. M.
Venue
Depression and Anxiety
Publisher
Wiley
Published
2015-09-18
Volume
32
Issue
12
Pages
871-891
ISSN
1091-4269 (ISSN-L)
OpenAlex
W1932597945
Cited by
76
References
7
FWCI
0.81
Type
journal article
Language
en
Open access
bronze
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
Funders
  • CAMH Foundation
  • Brain and Behavior Research Foundation
  • NHMRC Practitioner Fellowship (606907)
  • Cervel Neurotech
  • Lundbeck
  • ANT Neuro
  • Roche
  • Ontario Mental Health Foundation (OMHF)
  • CIHR
  • SickKids Foundation
  • The Ontario Ministry of Long Term Care
  • Brainsway, Ltd.
  • Pfizer and Merck
  • Sepracor, Inc., AstraZeneca
  • The Temerty Family and Grant Family
  • The Campbell Institute

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.